Inspire Pharmaceuticals Inc (ISPH) to Hold Q4 2007 Earnings Conference Call February 26

Inspire Pharmaceuticals Inc (NASDAQ:ISPH) will hold a conference call on February 26 at 10:00 am to discuss the fourth quarter earnings for 2007.

A biopharmaceutical company, Inspire Pharmaceuticals focuses on the discovery, development and commercialization of prescription pharmaceutical products.  The company portfolio includes products and potential products such as Elestate, Restasis, AzaSite, Prolacria, Bilastine, Denufosol tetrasodium, Epinastine nasal spray and INS115644.  The company co-promotes Elestate and Restasis with Allergan Inc (NYSE:AGN) in the United States.

Inspire entered a license agreement with InSite Vision Incorporated to obtain licensed rights to commercialize AzaSite.  AzaSite is a topical anti-infective product in the late stages of development.  The product is to be used to treat bacterial conjunctivitis.

For more Conference Call related events or to post your own events, visit:
http://events.finditt.com/Events_List.aspx?catid=12